COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Capital B confirms the acquisition of 6 BTC for EUR0.6 million, the holding of a total of 2,818 BTC, and a BTC Yield of 1,657.7% YTD
Capital B confirms final completion of a €0.6 million capital increase at €1.18 per share, acquiring 6 BTC. Temporary suspension of capital program with TOBAM. Group holds 2,818 BTC valued at €262.7 million -
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: ad pepper media International N.V.: Tripled revenue and record-high EBITDA in the third quarter of 2025
ad pepper media International N.V. tripled revenue and achieved record-high EBITDA in Q3 2025, driven by the acquisition of solute. Strong growth expected to continue -
-
COMMUNIQUÉ DE PRESSE
E+S Rück anticipates a stable market environment in Germany for 2026 and continued growth in demand for reinsurance protection
E+S Rück anticipates stable market environment in Germany for 2026, with continued growth in demand for reinsurance protection. Full range of innovative solutions offered -
-
COMMUNIQUÉ DE PRESSE
2025 Q3 Sales: Revenue of €6.1 Billion, Stable on an Organic Basis. Strong Financial Discipline. 2025 Guidance Confirmed
FORVIA reports stable organic sales of €6.1 billion in Q3 2025, strong financial discipline, and confirms 2025 guidance. Focus on efficiency measures and debt profile improvement -
COMMUNIQUÉ DE PRESSE
Press Release: Sanofi’s high-dose influenza vaccine demonstrates superior protection for older adults against hospitalization vs standard-dose
Sanofi's high-dose influenza vaccine Efluelda/Fluzone High-Dose shows superior protection for older adults by reducing hospitalizations. FLUNITY-HD study details robust evidence published in The Lancet -
COMMUNIQUÉ DE PRESSE
Communiqué de presse : Le vaccin antigrippal à haute dose de Sanofi démontre une protection supérieure contre les hospitalisations chez les séniors par rapport aux vaccins à dose standard
Le vaccin antigrippal à haute dose de Sanofi démontre une protection supérieure contre les hospitalisations chez les seniors par rapport aux vaccins à dose standard -
COMMUNIQUÉ DE PRESSE
CA T3: VENTES À 6,1 MILLIARDS D’EUROS, STABLES EN BASE ORGANIQUE. FORTE DISCIPLINE FINANCIÈRE. OBJECTIFS 2025 CONFIRMÉS
FORVIA confirme une stabilité des ventes au troisième trimestre 2025 malgré un effet devises négatif. La performance est portée par Electronics, Clean Mobility et LifeCycle Solutions. Forte discipline financière maintenue
